AXSM · Axsome Therapeutics, Inc. · Share Buybacks
$134.33
+1.96 (+1.48%)
At close · Nov 9
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$6.96B
Shares
52.60M
Volume · Nov 9
46.19K
Avg daily vol (3M)
844.34K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-03 | — | — | — | — | 10-Q , filed 2026-11-02 |
Key facts
CIK
1579428
CUSIP
05464T104
13F (30d)
214 filings
184 filers
Visit website
Investor relations